TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Purchased by NewEdge Advisors LLC
NewEdge Advisors LLC raised its stake in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 4,549.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,928 shares of the biopharmaceutical company’s stock after purchasing an additional 6,779 shares during the period. NewEdge […]
